US Patent 7812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+197 characters)
Article
Patent abstract
Mammalian GLP-2 mimetibodies, polypeptides and nucleic acids are disclosed. Methods of utilizing the mimetibodies and polypeptides to treat GLP-2 related diseases are also disclosed.
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses US Patent 7812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses
Infobox
Patent Number
0781212100
Patent Number
781212100
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078121210
Date of Patent
October 12, 2010
0Patent Application Number
118486350
Date Filed
August 31, 2007
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078121210
Date of Patent
October 12, 2010
0Patent Application Number
118486350
Date Filed
August 31, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses
Infobox
Is a
Patent jurisdiction
Patent number
07812121
Date of patent
October 12, 2010
Patent application number
11848635
Date Filed
August 31, 2007
Patent primary examiner
Find more entities like US Patent 7812121 GLP-2 mimetibodies, polypeptides, compositions, methods and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.